早期绝经与激素治疗对肺健康结局的影响:PLCO试验二次分析
结果显示,早期绝经增加吸烟者呼吸系统死亡风险(双侧卵巢切除术者HR 1.98),而MHT与吸烟者肺癌及呼吸系统死亡风险降低相关。
要点
- 吸烟者早期绝经应重点戒烟并接受肺癌筛查,不论绝经类型。
- MHT使用与吸烟者肺癌及呼吸疾病死亡风险降低相关。
- 双侧卵巢切除术的早期绝经者呼吸死亡风险最高。
核心结论
- 吸烟的早期绝经女性应针对性戒烟和肺癌筛查,无论绝经类型。
- 在吸烟者中,MHT使用者死于肺癌和呼吸系统疾病的可能性更低。
主要发现
- 在吸烟者中,早期绝经与多数肺部疾病和死亡结局风险增加相关,双侧卵巢切除术者呼吸死亡风险最高(HR 1.98,95%CI 1.34-2.92)。
- 在从不吸烟者中,自然绝经或双侧卵巢切除术的早期绝经与慢性支气管炎、全因、非癌症和呼吸死亡正相关,双侧卵巢切除术的呼吸死亡风险最高(HR 1.91,95%CI 1.16-3.12)。
- 曾经使用MHT与全因、非癌症和心血管死亡风险降低相关,不受绝经类型和吸烟状态影响。
- 在吸烟者中,MHT还与非卵巢癌、肺癌和呼吸死亡风险降低相关,且全因、非癌症和心血管死亡风险降低呈 duration-dependent 方式。
临床怎么用
- 对吸烟的早期绝经女性应强化戒烟干预和肺癌筛查,不考虑绝经类型。
- 在吸烟者中,MHT使用可能与肺癌和呼吸疾病死亡风险降低相关,可结合个体情况评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Early natural menopause (early-M; <45 years of age) increases the risk of lung morbidities and mortalities in smokers. However, it is largely unknown whether early-M due to surgery demonstrates similar effects and whether menopausal hormone therapy (MHT) is protective against lung diseases. OBJECTIVES: To assess the associations of early-M and MHT with lung morbidities and mortalities using the prospective Prostate, Lung, Colorectal and Ovarian (PLCO) trial. METHODS: We estimated the risk among 69 706 postmenopausal women in the PLCO trial, stratified by menopausal types and smoking status. RESULTS: Early-M was associated with an increased risk of most lung disease and mortality outcomes in ever smokers with the highest risk seen for respiratory mortality (HR 1.98, 95% CI 1.34 to 2.92) in those with bilateral oophorectomy (BO). Early-M was positively associated with chronic bronchitis, and all-cause, non-cancer and respiratory mortality in never smokers with natural menopause or BO, with the highest risk seen for BO- respiratory mortality (HR 1.91, 95% CI 1.16 to 3.12). Ever MHT was associated with reduced all-cause, non-cancer and cardiovascular mortality across menopause types regardless of smoking status and was additionally associated with reduced risk of non-ovarian cancer, lung cancer (LC) and respiratory mortality in ever smokers. Among smokers, ever MHT use was associated with a reduction in HR for all-cause, non-cancer and cardiovascular mortality in a duration-dependent manner. CONCLUSIONS: Smokers with early-M should be targeted for smoking cessation and LC screening regardless of menopause types. MHT users had a lower likelihood of dying from LC and respiratory diseases in ever smokers.
引用
- Gai X, Feng Y, Flores TM, et al. Early menopause and hormone therapy as determinants for lung health outcomes: a secondary analysis using the PLCO trial. Thorax. 2024. PMID: 38871464. doi:10.1136/thorax-2023-220956
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。